Verition Fund Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,164
Closed -$205K 2472
2022
Q3
$205K Buy
+1,164
New +$238K ﹤0.01% 2477

Other funds holding LH

Verition Fund Management's LH Position: Q1 2026 in Review

Verition Fund Management reduced its Labcorp (LH) stake by 76% in Q1 2026, selling an estimated $2.83M and leaving 3,268 shares worth $872K. The position accounts for 0.01% of the portfolio, ranked #1368.

Verition Fund Management first reported a position in LH in Q4 2013 and has held it in 33 quarters since. The position peaked at $24.4M in Q1 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Verition Fund Management held 3,268 shares of Labcorp worth $872K as of Q1 2026.
  • Verition Fund Management sold 10,447 Labcorp shares in Q1 2026, an estimated $2.83M.
  • Labcorp made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1368 holding.
  • Verition Fund Management first reported a position in Labcorp in Q4 2013 and has held it in 33 quarters since.
  • Verition Fund Management's Labcorp position peaked at $24.4M in Q1 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.